The observation that tumor protein TPD54 alters the cellular sensitivity to metformin treatment leads us to hypothesize that TPD54 might be involved in the regulation of PDH related mitochondrial function and cancer metabolism. This evidence concerns the gene TPD52L2 and cancer.